Showing results (541-550 of 652) with videos related to

Sort By:
Pageof 66
Journal of Crohn'S & Colitis|September 30, 2016
Long-term Efficacy of Vedolizumab for Ulcerative ColitisEdward V Loftus, Jean-Frédéric Colombel, Brian G Feagan, et al.
Clinical and Experimental Medicine|February 5, 2025
Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre studyCaterina Baldi, Stefano Gentileschi, Francesca Li Gobbi, et al.
Inflammatory Bowel Diseases|May 1, 2026
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trialAnita Afzali, Silvio Danese, Remo Panaccione, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn's Disease: A Canadian Multi-Centre Observational Cohort StudyHang Hock Shim, Christopher Ma, Paulo G Kotze, et al.
The Lancet. Gastroenterology & Hepatology|December 17, 2023
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trialSilvio Danese, Remo Panaccione, Brian G Feagan, et al.
The American Journal of Gastroenterology|December 6, 2012
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion processLaurent Peyrin-Biroulet, Vincent Billioud, Geert D'Haens, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2023
Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn's Disease ActivityVirginia Solitano, David F Schaeffer, Malcolm Hogan, et al.
Pageof 66